Azole resistance among clinical Aspergillus fumigatus species complex isolates in Greece: first detection of TR46-mediated resistance and azole-resistant cryptic species
JAC-Antimicrobial Resistance · 31.10.2026 · 8 (6)
DOI: 10.1093/jacamr/dlag238 ↗Kurz gefasst
Fachartikel in der Zeitschrift JAC-Antimicrobial Resistance, online erschienen am 02.11.2026. Verfasst von Maria Siopi und 11 weiteren Autor:innen. Beteiligte Einrichtung: Clinical Microbiology Laboratory, 'Attikon' University General Hospital, Medical School, National and Kapodistrian University of Athens, Athens, Gree…. Die Arbeit nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Asklepios Gilead 2014 Hellas Grants Programme, General Secretariat for Research and Innovation of Greece Grant PRO-sCAP, European Union-Next Generation EU.
Abstract (Originalsprache)
Objectives
To assess the prevalence of antifungal resistance among clinical Aspergillus fumigatus species complex (SC) isolates in Greece, focusing on azole resistance and its underlying molecular mechanisms.
Methods
A total of 249 clinical A. fumigatus SC isolates were collected from geographically distinct centres across Greece. Antifungal susceptibility testing (AFST) was conducted according to EUCAST guidelines. Cryptic species and azole-resistant A. fumigatus (ARAf) isolates underwent confirmatory molecular identification. ARAf sensu stricto (SS) isolates were further analysed by CYP51A gene and promoter sequencing to detect resistance-associated mutations.
Results
Most isolates (246/249; 99%) were identified as A. fumigatus SS, while three isolates were molecularly identified as A. fumigatiaffinis, A. lentulus and A. pseudoviridinutans. Amphotericin B and echinocandins demonstrated good in vitro activity against A. fumigatus SS, whereas posaconazole was the most active azole in vitro. Cryptic species exhibited reduced susceptibility compared with A. fumigatus SS. Two isolates (1%; A. fumigatiaffinis and A. lentulus) were amphotericin B-resistant. Five isolates (2%) were ARAf, including all three cryptic species (from patients with chronic pulmonary aspergillosis; one pan-ARAf) and two A. fumigatus SS strains. One ARAf SS isolate (from a cystic fibrosis patient) was pan-ARAf and harboured the TR46/Y121F/T289A CYP51A mutation, while the second (from an ICU patient) displayed resistance to itraconazole, isavuconazole and posaconazole without detectable CYP51A mutations.
Conclusions
Although the clinical ARAf rate remains low in Greece, the first detection of pan-azole resistance associated with environmentally driven resistance mechanisms or cryptic species highlights the importance of surveillance, accurate species identification and routine AFST.
Autor:innen und Institutionen
- Clinical Microbiology Laboratory, 'Attikon' University General Hospital, Medical School, National and Kapodistrian University of Athens, Athens, Greece.
- Department of Microbiology, School of Medicine, National and Kapodistrian University of Athens, Athens, Greece.
- Department of Microbiology, 'Aghia Sophia' Children's Hospital, Athens, Greece.
- Infectious Diseases Unit, 3rd Department of Pediatrics, Aristotle University School of Medicine and 'Hippokration' General Hospital, Thessaloniki, Greece.
- Laboratory of Clinical Microbiology and Microbial Pathogenesis, School of Medicine, University of Crete, Heraklion, Crete, Greece.
- Department of Clinical Microbiology, 'Alexandra' General Hospital, Athens, Greece.
ORCID-Profile: Maria Siopi, Ana Alastruey-Izquierdo, Joseph Meletiadis
Förderung
- Asklepios Gilead 2014 Hellas Grants Programme
- General Secretariat for Research and Innovation of Greece Grant PRO-sCAP
- European Union-Next Generation EU
Zitieren
APA
Siopi, M., Vargiami, M., Beredaki, M. I., Velegraki, A., Zachariadou, L., Roilides, E., Chamilos, G., Antonopoulou, S., Skoura, L., Alastruey-Izquierdo, A., Pournaras, S., & Meletiadis, J. (2026). Azole resistance among clinical Aspergillus fumigatus species complex isolates in Greece: first detection of TR46-mediated resistance and azole-resistant cryptic species. JAC-Antimicrobial Resistance, 8(6). https://doi.org/10.1093/jacamr/dlag238
Vancouver
Siopi M, Vargiami M, Beredaki MI, Velegraki A, Zachariadou L, Roilides E, et al. Azole resistance among clinical Aspergillus fumigatus species complex isolates in Greece: first detection of TR46-mediated resistance and azole-resistant cryptic species. JAC-Antimicrobial Resistance. 2026;8(6). doi:10.1093/jacamr/dlag238
BibTeX
@article{Siopi2026,
author = {Siopi, Maria and Vargiami, Margarita and Beredaki, Maria-Ioanna and Velegraki, Aristea and Zachariadou, Levantia and Roilides, Emmanuel and Chamilos, Georgios and Antonopoulou, Stavroula and Skoura, Lemonia and Alastruey-Izquierdo, Ana and Pournaras, Spyros and Meletiadis, Joseph},
title = {Azole resistance among clinical Aspergillus fumigatus species complex isolates in Greece: first detection of TR46-mediated resistance and azole-resistant cryptic species},
journal = {JAC-Antimicrobial Resistance},
year = {2026},
volume = {8},
number = {6},
doi = {10.1093/jacamr/dlag238}
}
EUVIMED